1. Home
  2. BNED vs DCTH Comparison

BNED vs DCTH Comparison

Compare BNED & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

HOLD

Current Price

$7.70

Market Cap

296.0M

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$9.31

Market Cap

323.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNED
DCTH
Founded
1965
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
296.0M
323.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNED
DCTH
Price
$7.70
$9.31
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$23.00
AVG Volume (30 Days)
307.6K
504.2K
Earning Date
03-09-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
0.03
Revenue
$1,677,191,000.00
$79,603,000.00
Revenue This Year
N/A
$132.21
Revenue Next Year
N/A
$33.88
P/E Ratio
$162.95
$269.81
Revenue Growth
7.64
251.54
52 Week Low
$5.90
$8.12
52 Week High
$12.21
$18.23

Technical Indicators

Market Signals
Indicator
BNED
DCTH
Relative Strength Index (RSI) 37.61 42.36
Support Level $8.57 $8.94
Resistance Level $9.05 $10.30
Average True Range (ATR) 0.47 0.52
MACD -0.17 -0.08
Stochastic Oscillator 17.89 23.70

Price Performance

Historical Comparison
BNED
DCTH

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also a textbook wholesaler and inventory management hardware and software provider. It offers course materials through physical and online bookstores, including new and used print textbooks, rental options, digital textbooks, and publisher-hosted digital courseware. Products are also offered directly to students through Textbooks.com. The majority of the company's revenue is derived from the sale of products through its bookstore locations, including virtual bookstores, and the bookstore affiliated e-commerce websites.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: